Apontis Pharma AG (APPH.DE)

EUR 11.15

(0.45%)

Total Liabilities Summary of Apontis Pharma AG

  • Apontis Pharma AG's latest annual total liabilities in 2023 was 27.2 Million EUR , up 48.74% from previous year.
  • Apontis Pharma AG's latest quarterly total liabilities in 2024 Q2 was 17.23 Million EUR , down -36.63% from previous quarter.
  • Apontis Pharma AG reported annual total liabilities of 18.28 Million EUR in 2022, up 36.27% from previous year.
  • Apontis Pharma AG reported annual total liabilities of 13.41 Million EUR in 2021, down -48.84% from previous year.
  • Apontis Pharma AG reported quarterly total liabilities of 27.2 Million EUR for 2023 Q4, up 76.62% from previous quarter.
  • Apontis Pharma AG reported quarterly total liabilities of 27.2 Million EUR for 2023 FY, up 48.74% from previous quarter.

Annual Total Liabilities Chart of Apontis Pharma AG (2023 - 2018)

Historical Annual Total Liabilities of Apontis Pharma AG (2023 - 2018)

Year Total Liabilities Total Liabilities Growth
2023 27.2 Million EUR 48.74%
2022 18.28 Million EUR 36.27%
2021 13.41 Million EUR -48.84%
2020 26.23 Million EUR 1.11%
2019 25.94 Million EUR -6.7%
2018 27.8 Million EUR 0.0%

Peer Total Liabilities Comparison of Apontis Pharma AG

Name Total Liabilities Total Liabilities Difference
MPH Health Care AG 15.38 Million EUR -76.779%
Dermapharm Holding SE 1.62 Billion EUR 98.328%
Evotec SE 1.17 Billion EUR 97.693%
MERCK Kommanditgesellschaft auf Aktien 22.36 Billion EUR 99.878%
PharmaSGP Holding SE 91.54 Million EUR 70.288%
SynBiotic SE 19.59 Million EUR -38.839%